title: Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda.
authors.affiliation: KNCV Tuberculosis Foundation, The Hague, The Netherlands. cobelensf@kncvtbc.nl
authors.forename: Frank G J
authors.initials: FG
authors.lastname: Cobelens
authors.forename: Einar
authors.initials: E
authors.lastname: Heldal
authors.forename: Michael E
authors.initials: ME
authors.lastname: Kimerling
authors.forename: Carole D
authors.initials: CD
authors.lastname: Mitnick
authors.forename: Laura J
authors.initials: LJ
authors.lastname: Podewils
authors.forename: Rajeswari
authors.initials: R
authors.lastname: Ramachandran
authors.forename: Hans L
authors.initials: HL
authors.lastname: Rieder
authors.forename: Karin
authors.initials: K
authors.lastname: Weyer
authors.forename: Matteo
authors.initials: M
authors.lastname: Zignol
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D014943:Global Health; D006801:Humans; D012106:Research; D018088:Tuberculosis, Multidrug-Resistant / Q000188:drug therapy / Q000517:prevention & control / Q000628:therapy*
chemical_list: D000995:Antitubercular Agents